相关实验视频
Updated: Jun 5, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
最近的法庭裁决可能会增加340B计划的规模和行政复杂性
Sayeh Nikpay1, John P Bruno2, Colleen Carey3
1Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN 55455, United States.
对340B药品定价计划的新定义可以使符合条件的处方增加25%,可能使医院的利增加三分之一. 这一变化也可能使该计划内的患者处方冲突翻倍.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 获得医疗保健的机会.
背景情况:
- 340B药品定价计划使符合条件的医疗保健机构能够以降低价格购买门诊药物.
- 该计划的利旨在资助患者护理,取决于患者的资格标准.
- 最近的一项法律挑战改变了卫生资源和服务管理局 (HRSA) 对合格患者的定义.
研究的目的:
- 模拟新患者定义对340B计划范围和支出的影响.
- 量化340B资格处方填充和相关利的潜在增长.
- 根据修订后的定义,评估设施间冲突的可能性.
主要方法:
- 利用 2018 年的医疗保险 (Medicare) D 部分数据进行模拟.
- 根据现有和新的患者资格定义,比较处方药填充量和计划支出.
- 分析了有资格获得340B折扣的填充比例和潜在冲突.
主要成果:
- 新的患者定义可以使医疗保险D部分的340B符合条件的填充量增加25% (从12%增加到16%).
- 受到设施间冲突的填充比例可能会翻一番,从1%到2%不等.
- 估计在340B计划中,被覆盖实体的利可能增加约三分之一.
结论:
- 预计修订后的患者定义将大大扩大340B计划的覆盖范围.
- 增加的资格和潜在的冲突需要仔细的计划管理和政策考虑.
- 这些发现表明,参与340B计划的医疗保健提供者将面临巨大的财务影响.
更多相关视频
07:26Executing Complexity-Increasing Queries in Relational MySQL and NoSQL MongoDB and EXist Size-Growing ISO/EN 13606 Standardized EHR Databases
Published on: March 19, 2018
05:30Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
Published on: February 14, 2025
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
Standards of Care I